(Q33938850)

English

Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

title

Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

Eric Wooltorton

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

language of work or name

English

0 references

publication date

7 April 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

published in

Canadian Medical Association Journal

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

volume

172

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

page(s)

1179-1180

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

cites work

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=557066

retrieved

5 July 2018

Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=557066

retrieved

29 October 2018

Identifiers

DOI

10.1503/CMAJ.050373

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

PubMed publication ID

15817641

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15817641

retrieved

30 July 2017

ResearchGate publication ID

7918427

0 references

(Q33938850)

Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)